Comparative efficacy and safety of anakinra and canakinumab in patients with scpVEXAS/scp syndrome – an international multicenter study

Journal:
Arthritis & Rheumatology
Published:
DOI:
10.1002/art.43384
Affiliations:
31
Authors:
36
Institutions Authors Share
San Raffaele Scientific Institute, Italy
4.000000
0.11
Saint Antoine Hospital, France
4.000000
0.11
Tel Aviv Sourasky Medical Center, Israel
3.500000
0.10
Tel Aviv University (TAU), Israel
2.500000
0.07
Soroka Medical Center, Israel
1.000000
0.03
Cochin Hospital, France
1.000000
0.03
Hadassah Medical Center, HUJI, Israel
1.000000
0.03
Bichat-Claude Bernard Hospital, France
1.000000
0.03
Centre Hospitalier Départemental Vendée, France
1.000000
0.03
Immuno-Rhumathologie Moléculaire (IRM), France
1.000000
0.03
CHU de Bordeaux, France
1.000000
0.03
CHU Clermont-Ferrand, France
1.000000
0.03
Centre Hospitalier de Dax - Côte d'Argent, France
1.000000
0.03
Rennes University Hospital (CHU Rennes), France
1.000000
0.03
University Hospital Nantes (CHU de Nantes), France
1.000000
0.03
Saint-Éloi Hospital, France
1.000000
0.03
Toulouse University Hospital (CHU-Toulouse), France
1.000000
0.03
University Hospitals of Strasbourg (HUS), France
1.000000
0.03
Hôpital Saint-Louis, France
1.000000
0.03
Centre Hospitalier Lyon-Sud, HCL, France
1.000000
0.03
Institut Cochin, France
1.000000
0.03
Centre national de Référence des Maladies AutoInflammatoires et de l'Amylose Inflammatoire (CEREMAIA), France
1.000000
0.03
Maastricht University (UM), Netherlands
0.500000
0.01
Centre Hospitalier du Haut Anjou, France
0.500000
0.01
Centre Hospitalier Universitaire d'Angers (CHU d'Angers), France
0.500000
0.01
Chaim Sheba Medical Center at Tel HaShomer, Israel
0.500000
0.01
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France
0.500000
0.01
Université de Toulouse, France
0.500000
0.01
Dijon University Hospital, France
0.500000
0.01
Unité Mixte de Recherche RIGHT, France
0.500000
0.01